Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
Read Article
News
2024
2023
Archive
Search news articles
October 31, 2017
IMPEL NEUROPHARMA ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 CLINICAL TRIAL OF INP104 FOR TREATMENT OF ACUTE MIGRAINE HEADACHE
October 26, 2017
CRINETICS PHARMACEUTICALS INITIATES PHASE 1 STUDY OF LEAD CANDIDATE CRN00808 FOR ACROMEGALY
October 24, 2017
SCPHARMACEUTICALS FILES FOR A $100 MILLION IPO
October 18, 2017
SPYRYX BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 2 CLINICAL TRIAL OF SPX-101 FOR THE TREATMENT OF CYSTIC FIBROSIS
October 18, 2017
PEAR THERAPEUTICS RECEIVES EXPEDITED ACCESS PATHWAY DESIGNATION FROM FDA FOR RESET-O™ PRESCRIPTION DIGITAL THERAPEUTIC TO TREAT OPIOID USE DISORDER
October 18, 2017
VIVEVE RELEASES PRELIMINARY THIRD QUARTER 2017 FINANCIAL RESULTS
October 16, 2017
APREA THERAPEUTICS ANNOUNCES FIRST PATIENTS ENROLLED IN PHASE IB/II CLINICAL STUDY OF APR-246 FOR THE TREATMENT OF ESOPHAGEAL CANCER
October 6, 2017
FLEXION THERAPEUTICS ANNOUNCES FDA APPROVAL OF ZILRETTA™ (TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION) FOR OSTEOARTHRITIS (OA) KNEE PAIN
October 3, 2017
IMPEL NEUROPHARMA BOARD ANNOUNCES APPOINTMENT OF JON CONGLETON AS CEO
September 29, 2017
NOHLA THERAPEUTICS AWARDED $6.9 MILLION GRANT FROM CIRM FOR THE TREATMENT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA
« Previous Page
1
…
67
68
69
70
71
…
103